메뉴 건너뛰기




Volumn 73, Issue 7, 2008, Pages 801-803

Acute kidney injury: Better biomarkers and beyond

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GELATINASE B; N ACETYL BETA GLUCOSAMINIDASE;

EID: 40849133976     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.17     Document Type: Note
Times cited : (20)

References (10)
  • 1
    • 42149105187 scopus 로고    scopus 로고
    • Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review
    • publication, 19 December, doi:10.1038/sj.ki.5002729
    • Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int advance online publication, 19 December 2007, doi:10.1038/sj.ki.5002729.
    • (2007) Kidney Int advance online
    • Coca, S.G.1    Yalavarthy, R.2    Concato, J.3    Parikh, C.R.4
  • 2
    • 40849142159 scopus 로고    scopus 로고
    • Urinary biomarkers in the early diagnosis of acute kidney injury
    • Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008; 73: 863-869.
    • (2008) Kidney Int , vol.73 , pp. 863-869
    • Han, W.K.1    Waikar, S.S.2    Johnson, A.3
  • 3
    • 13844322072 scopus 로고    scopus 로고
    • Lessons from controversy: Ovarian cancer screening and serum proteomics
    • Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst 2005; 97: 315-319.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 315-319
    • Ransohoff, D.F.1
  • 4
    • 33846563409 scopus 로고    scopus 로고
    • Why most published research findings are false
    • Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2: e124.
    • (2005) PLoS Med , vol.2
    • Ioannidis, J.P.1
  • 5
    • 0035908491 scopus 로고    scopus 로고
    • Phases of biomarker development for early detection of cancer
    • Pepe MS, Etzioni R, Feng Z et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001; 93: 1054-1061.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1054-1061
    • Pepe, M.S.1    Etzioni, R.2    Feng, Z.3
  • 6
    • 0028012745 scopus 로고
    • Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group
    • Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994; 271: 389-391.
    • (1994) JAMA , vol.271 , pp. 389-391
    • Jaeschke, R.1    Guyatt, G.2    Sackett, D.L.3
  • 7
    • 33745725903 scopus 로고    scopus 로고
    • Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery
    • Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199-203.
    • (2006) Kidney Int , vol.70 , pp. 199-203
    • Parikh, C.R.1    Mishra, J.2    Thiessen-Philbrook, H.3
  • 8
    • 38749115028 scopus 로고    scopus 로고
    • Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery
    • publication, 19 December, doi:10.1038/sj.ki.5002721
    • Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int advance online publication, 19 December 2007, doi:10.1038/sj.ki.5002721.
    • (2007) Kidney Int advance online
    • Portilla, D.1    Dent, C.2    Sugaya, T.3
  • 9
    • 0033603794 scopus 로고    scopus 로고
    • Users' guides to the medical literature. XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group
    • Bucher HC, Guyatt GH, Cook DJ et al. Users' guides to the medical literature. XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999; 282: 771-778.
    • (1999) JAMA , vol.282 , pp. 771-778
    • Bucher, H.C.1    Guyatt, G.H.2    Cook, D.J.3
  • 10
    • 0033026235 scopus 로고    scopus 로고
    • Users' guides to the medical literature. XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group
    • Barratt A, Irwig L, Glasziou P et al. Users' guides to the medical literature. XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 1999; 281: 2029-2034.
    • (1999) JAMA , vol.281 , pp. 2029-2034
    • Barratt, A.1    Irwig, L.2    Glasziou, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.